CCR9 and neoplasm: In addition, on non-hematopoietic tumors with forced CCR9 expression, 92R treatment had also an effect decreasing the number of subcutaneous tumor-carrying animals, as well as the tumor’s size, as demonstrated with HEK293T-CCR9 derived solid tumors as a proof-of-principle.